Jennotte, O., Koch, N. (Other coll.), Collard, L. (Other coll.), Lechanteur, A. (Other coll.), & Evrard, B. (Other coll.). (26 March 2019). Hot melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Poster presentation]. 3rd European Conference on Pharmaceutics, Bologne, Italy. |
Jennotte, O., Koch, N., Collard, L., Lechanteur, A., & Evrard, B. (19 December 2018). Hot melt extrusion as a solvent-free technique for the formation of a polymeric amorphous solid dispersion of atorvastatin [Paper presentation]. CIRM Day, Liège, Belgium. |
Thiry, J., Kok, M., Collard, L., Frere, A., Krier, F., Fillet, M., & Evrard, B. (01 March 2017). Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule. European Journal of Pharmaceutical Sciences, 99, 1-8. doi:10.1016/j.ejps.2016.12.001 Peer Reviewed verified by ORBi |
Thiry, J., Kok, M., Collard, L., Frère, A., Krier, F., Fillet, M., & Evrard, B. (15 November 2016). Original study of the bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the three Rs rule [Poster presentation]. AAPS 2016 Denver. |
Reschner, A., Shim, Y. H., Dubois, P., Delvenne, P., Evrard, B., Marcelis, L., Moucheron, C., Kirsch-De Mesmaeker, A., Defrancq, E., Raes, M., Piette, J., Collard, L., & Piel, G. (2013). Evaluation of a new biocompatible poly(N-(morpholino ethyl methacrylate)-based copolymer for the delivery of ruthenium oligonucleotides, targeting HPV16 E6 oncogene. Journal of Biomedical Nanotechnology, 9, 1-9. doi:10.1166/jbn.2013.1634 Peer reviewed |
Frère, A., Kawalec, M., Collard, L., Matheus, N., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (22 October 2012). Characterization and transfection experiments of polyplexes targeting HDAC7 [Poster presentation]. NanoFar Autumn School, Angers, France. |
Reschner, A., Shim, Y. H., Dubois, P., Evrard, B., DELVENNE, P., Marcelis, L., Moucheron, C., Kirsch Demmesmacher, A., Defrancq, E., Raes, M., Collard, L., & Piel, G. (2012). EVALUATION OF A NEW BIOCOMPATIBLE POLY(N-(MORPHOLINO ETHYL METHACRYLATE)-BASED COPOLYMER FOR THE DELIVERY OF Ruthenium oligonucleotides, targeting HPV16 E6 oncogene [Poster presentation]. GTRV, Paris, France. |
Piel, G., Collard, L., Evrard, B., Delvenne, P., Dubois, P., & Reschner, A. (October 2010). POLYPLEXES TARGETING E6: OPTIMIZATION OF THE FORMULATIONS IN TERMS OF TRANSFECTION, TOXICITY AND EFFICIENCY [Poster presentation]. 2nd Conference Innovation in Drug Delivery: From Preformulation to development through Innovative Evaluation Process, Aix en Provence, France. |
Gadisseur, R., Cataldo, D., Collard, L., Chapelle, J.-P., & Cavalier, E. (2009). Allergie au venin d'hyménoptère et tests de laboratoires : de nouvelles approches pour la prise en charge des patients à haut risque de réaction sévère. Revue Médicale de Liège, 64 (11), 570-5. Peer reviewed |
Nizet, D., Zalfen, A., Collard, L., Krier, F., Jérôme, C., Frankenne, F., Delattre, L., & Evrard, B. (2007). Development of an original intra-uterine implant allowed specific release kinetics of several drugs [Poster presentation]. Innovation in drug delivery: from biomaterials to devices, Naples, Italy. |
Nizet, D., Zalfen, A., Collard, L., Krier, F., Jérôme, C., Frankenne, F., Maquet, V., Delattre, L., & Evrard, B. (2007). Controlled release of drugs from an original multi-component device [Poster presentation]. Biomedica 2007, aachen, Germany. |
Hubert, C., Rozet, E., Boulanger, B., Dewé, W., Breuer, A., Collard, L., Evrard, B., & Hubert, P. (May 2006). Validation of a LC method for the determination of levonorgestrel released from a polymeric matrix. A two days protocol [Poster presentation]. Drug Analysis 2006, Namur, Belgium. |